Ian F. Tannock - Publications, H-index & Citations

Ian F. Tannock

Princess Margaret Cancer Centre and University of Toronto

111H指数

616论文数

6.2W被引数

收录论文 182

发表时间

Adherence of Published Randomized Phase 3 Cancer Trials to Principles Proposed by Common-Sense Oncology 已发表随机化III期癌症试验对“常识性肿瘤学”所提出原则的遵循情况

European Journal of Cancer

IF7.1

2025-10-02

PREAI

Omar Abdihamid; Bishal Gyawali; Christopher M. Booth; Elizabeth A Eisenhauer; Wilma M. Hopman; Brian Shkabari; Dario Trapani; Haydee C. Verduzco-Aguirre; Brooke E. Wilson; Ian F. Tannock

Non-financial conflicts of interest 非金融性利益冲突

Nature Reviews Clinical Oncology

IF82.2

2025-09-03

PREAI

Saroj Niraula; Ian F. Tannock

Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer 在晚期癌症临床试验中报告与健康相关的生活质量数据时，应答者标准的重要性：常识肿瘤学与欧洲癌症研究与治疗组织的建议

lancet oncology

IF0

2025-09-01

PREAI

Ian F Tannock; Madeline Lee Pe; Christopher M Booth; Michael Brundage; Nathan I Cherny; Corneel Coens; Elizabeth A Eisenhauer; Jan Geissler; Johannes M Giesinger; Bishal Gyawali; Sjoukje F Oosting; Gregory R Pond; Jaap C Reijneveld; Enrique Soto-Perez-de-Celis; Michelle Tregear; Winette T A van der Graaf

Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing 阐明SONIA的作用: 支持CDK4/6抑制剂时机的学术证据

Nature Reviews Clinical Oncology

IF82.2

2025-07-28

PREAI

Avi Petroff; Ian F. Tannock; Daniel A. Goldstein

Guidance for discussants of randomized cancer trials at major meetings 重大会议中随机化癌症试验讨论员的指导原则

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-05-01

PREAI

Eisenhauer, Elizabeth A.; Abdihamid, Omar; Booth, Christopher M.; Cherny, Nathan; Fojo, Antonio T.; Gyawali, Bishal; Marini, Bernard L.; Mohyuddin, Ghulam Rehman; Pe, Madeline; Pond, Gregory R.; Soto-Perez-de-Celis, Enrique; Tannock, Ian F.; Trapani, Dario; Tregear, Michelle; van der Graaf, Winette T. A.; Wilson, Brooke E.

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring 尿路上皮癌化疗免疫治疗试验的差异化删失重分析

JAMA NETWORK OPEN

IF9.7

2025-01-22

OAAI

Meirson, Tomer; Ofer, Jonathan; Zimhony-Nissim, Noa; Bareket-Samish, Avital; Markel, Gal; Neiman, Victoria; Cherny, Nathan; Goldstein, Daniel A.; Gyawali, Bishal; Tannock, Ian; Rosenbaum, Eli

RETRACTION: Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors (Retraction of Vol 18, Pg 347, 2016)

NEOPLASIA

IF7.7

2024-05-01

OAAI

Tan, Qian; Wang, Marina; Yu, Man; Zhang, Junyan; Bristow, Robert G.; Hill, Richard P.; Tannock, Ian F.

The Lancet Commission on prostate cancer: planning for the surge in cases 柳叶刀前列腺癌委员会: 规划病例激增

LANCET

IF88.5

2024-04-01

OAAI

James, Nicholas; Tannock, Ian; N'Dow, James; Feng, Felix; Gillessen, Silke; Ali, Syed Adnan; Trujillo, Blanca; Al-Lazikani, Bissan; Attard, Gerhardt; Bray, Freddie; Comperat, Eva; Eeles, Ros; Fatiregun, Omolara; Grist, Emily; Halabi, Susan; Haran, Aine; Herchenhorn, Daniel; Hofman, Michael S.; Jalloh, Mohamed; Loeb, Stacy; Macnair, Archie; Mahal, Brandon; Mendes, Larissa; Moghul, Masood; Moore, Caroline; Morgans, Alicia; Morris, Michael; Murphy, Declan; Murthy, Vedang; Nguyen, Paul L.; Padhani, Anwar; Parker, Charles; Rush, Hannah; Sculpher, Mark; Soule, Howard; Sydes, Matthew R.; Tilki, Derya; Tunariu, Nina; Villanti, Paul; Xie, Li-Ping

RETRACTION: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy (Retraction of Vol 112, Pg 832, 2015)收回: 泮托拉唑通过抑制自噬增强多西他赛对人肿瘤异种移植物的活性的作用 (卷112，Pg 832，2015)

BRITISH JOURNAL OF CANCER

IF6.8

2024-03-20

OAAI

Tan, Q.; Joshua, A. M.; Saggar, J. K.; Yu, M.; Wang, M.; Kanga, N.; Zhang, J. Y.; Chen, X.; Wouters, B. G.; Tannock, I. F.

Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours

BRITISH JOURNAL OF CANCER

IF6.8

2022-12-23

OAAI

Tannock, Ian F.; Gordon Steel, G.

Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

NATURE MEDICINE

IF50

2022-10-06

OAAI

Hirsch, Ian; Goldstein, Daniel A.; Tannock, Ian F.; Butler, Marcus O.; Gilbert, Duncan C.

The dosing of ibrutinib and related Bruton's tyrosine kinase inhibitors: eliminating the use of brute force COMMENT

BLOOD ADVANCES

IF7.1

2022-08-30

OAAI

Ratain, Mark J.; Tannock, Ian F.; Lichter, Allen S.

Priorities for cancer research in low- and middle-income countries: a global perspective

NATURE MEDICINE

IF50

2022-04-19

159

OAAI

Pramesh, C. S.; Badwe, Rajendra A.; Bhoo-Pathy, Nirmala; Booth, Christopher M.; Chinnaswamy, Girish; Dare, Anna J.; de Andrade, Victor Piana; Hunter, David J.; Gopal, Satish; Gospodarowicz, Mary; Gunasekera, Sanjeeva; Ilbawi, Andre; Kapambwe, Sharon; Kingham, Peter; Kutluk, Tezer; Lamichhane, Nirmal; Mutebi, Miriam; Orem, Jackson; Parham, Groesbeck; Ranganathan, Priya; Sengar, Manju; Sullivan, Richard; Swaminathan, Soumya; Tannock, Ian F.; Tomar, Vivek; Vanderpuye, Verna; Varghese, Cherian; Weiderpass, Elisabete

Improving access to immunotherapy in low- and middle-income countries

ANNALS OF ONCOLOGY

IF65.4

2022-04-01

OAAI

Patel, A.; Goldstein, D. A.; Tannock, I. F.

How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy

ANNALS OF ONCOLOGY

IF65.4

2021-07-01

OAAI

Fundytus, A.; Booth, C. M.; Tannock, I. F.

The European Union and personalised cancer medicine

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-06-01

PREAI

Hickman, John A.; Tannock, Ian F.; Meheus, Lydie; Hutchinson, Lisa

Have investigators forgotten how to write?

ANNALS OF ONCOLOGY

IF65.4

2021-04-01

OAAI

Tannock, I. F.

Cautionary tails

ANNALS OF ONCOLOGY

IF65.4

2021-01-01

OAAI

Del Paggio, J. C.; Tannock, I. F.

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

JCO GLOBAL ONCOLOGY

IF3

2020-11-01

OAAI

Patel, Amol; Tannock, Ian F.; Srivastava, Priyanka; Biswas, Bivas; Gupta, Vineet Govinda; Batra, Atul; Bhethanabhotla, Sainath; Pramanik, Raja; Mahindru, Shubh; Tilak, Tvsvgk; Das, Chandan Krishna; Mehta, Prashant

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration -resistant prostate cancer y 不同种族背景的转移性去势抵抗性前列腺癌患者的临床结局

ANNALS OF ONCOLOGY

IF65.4

2020-07-01

OAAI

Halabi, S.; Dutta, S.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Thompson, I. M., Jr.; Chi, K. N.; De Bono, J. S.; Araujo, J. C.; Logothetis, C.; Eisenberger, M. A.; Quinn, D. I.; Fizazi, K.; Morris, M. J.; Higano, C. S.; Tannock, I. F.; Small, E. J.; Kelly, W. K.

研究方向